These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34638370)

  • 41. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.
    Jaaback K; Johnson N
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005340. PubMed ID: 16437527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does intraperitoneal chemotherapy benefit optimally debulked epithelial ovarian cancer patients after neoadjuvant chemotherapy?
    Le T; Latifah H; Jolicoeur L; Weberpals J; Faught W; Hopkins L; Fung MF
    Gynecol Oncol; 2011 Jun; 121(3):451-4. PubMed ID: 21402403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer.
    Wright AA; Cronin A; Milne DE; Bookman MA; Burger RA; Cohn DE; Cristea MC; Griggs JJ; Keating NL; Levenback CF; Mantia-Smaldone G; Matulonis UA; Meyer LA; Niland JC; Weeks JC; O'Malley DM
    J Clin Oncol; 2015 Sep; 33(26):2841-7. PubMed ID: 26240233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group.
    Markman M; Bundy BN; Alberts DS; Fowler JM; Clark-Pearson DL; Carson LF; Wadler S; Sickel J
    J Clin Oncol; 2001 Feb; 19(4):1001-7. PubMed ID: 11181662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intraperitoneal chemotherapy for advanced ovarian and peritoneal cancers in patients following interval debulking surgery or primary cytoreductive surgery: Tom Baker Cancer Centre experience from 2006 to 2009.
    Nelson G; Lucero CA; Chu P; Nation J; Ghatage P
    J Obstet Gynaecol Can; 2010 Mar; 32(3):263-9. PubMed ID: 20500971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intraperitoneal chemotherapy for advanced epithelial ovarian malignancy: lessons learned.
    Bunting M; Chan W; Brand A; Blomfield P
    Aust N Z J Obstet Gynaecol; 2009 Dec; 49(6):667-71. PubMed ID: 20070720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): an NRG Oncology/Gynecologic Oncology Group study.
    McMeekin DS; Sill MW; Walker JL; Moore KN; Waggoner SE; Thaker PH; Rizack T; Hoffman JS; Fracasso PM
    Gynecol Oncol; 2015 Jul; 138(1):36-40. PubMed ID: 25958319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancer.
    Suidan RS; Zhou Q; Iasonos A; O'Cearbhaill RE; Chi DS; Long Roche KC; Tanner EJ; Denesopolis J; Barakat RR; Zivanovic O
    Int J Gynecol Cancer; 2015 May; 25(4):599-606. PubMed ID: 25664437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial.
    Monk BJ; Colombo N; Oza AM; Fujiwara K; Birrer MJ; Randall L; Poddubskaya EV; Scambia G; Shparyk YV; Lim MC; Bhoola SM; Sohn J; Yonemori K; Stewart RA; Zhang X; Perkins Smith J; Linn C; Ledermann JA
    Lancet Oncol; 2021 Sep; 22(9):1275-1289. PubMed ID: 34363762
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian Cancer.
    Boisen MM; Lesnock JL; Richard SD; Beriwal S; Kelley JL; Zorn KK; Edwards RP
    Int J Gynecol Cancer; 2016 May; 26(4):626-31. PubMed ID: 27051048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraperitoneal chemotherapy for epithelial ovarian cancer - single center experience.
    Jaka RC; Somashekhar SP; Zaveri SS; Ahmed Z; Ashwin KR
    Indian J Surg Oncol; 2012 Sep; 3(3):262-6. PubMed ID: 23997520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-Term Survival Analysis of Intraperitoneal versus Intravenous Chemotherapy for Primary Ovarian Cancer and Comparison between Carboplatin- and Cisplatin-based Intraperitoneal Chemotherapy.
    Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    J Korean Med Sci; 2017 Dec; 32(12):2021-2028. PubMed ID: 29115086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up.
    Fujiwara K; Sakuragi N; Suzuki S; Yoshida N; Maehata K; Nishiya M; Koshida T; Sawai H; Aotani E; Kohno I
    Gynecol Oncol; 2003 Sep; 90(3):637-43. PubMed ID: 13678738
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer.
    Fujiwara K; Markman M; Morgan M; Coleman RL
    Gynecol Oncol; 2005 Apr; 97(1):10-5. PubMed ID: 15790431
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Nursing care for ovarian cancer patients with intraperitoneal chemotherapy].
    Lu YY; Chou JF; Tsao LI; Liang SY; Wu SF
    Hu Li Za Zhi; 2015 Feb; 62(1):87-91. PubMed ID: 25631188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intraperitoneal chemotherapy for patients with advanced ovarian cancer: a review of the evidence and standards for the delivery of care.
    Fung-Kee-Fung M; Provencher D; Rosen B; Hoskins P; Rambout L; Oliver T; Gotlieb W; Covens A;
    Gynecol Oncol; 2007 Jun; 105(3):747-56. PubMed ID: 17368522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paclitaxel maintenance chemotherapy following intraperitoneal chemotherapy for ovarian cancer.
    Robinson WR; Davis N; Rogers AS
    Int J Gynecol Cancer; 2008; 18(5):891-5. PubMed ID: 17944912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gynecological malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II study.
    Newman E; Potmesil M; Ryan T; Marcus S; Hiotis S; Yee H; Norwood B; Wendell M; Muggia F; Hochster H
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S97-100. PubMed ID: 16399443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Feasibility of neoadjuvant and adjuvant intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer: A single-center experience.
    Liu Y; Cao L; Chen W; Wang J; Wang W; Liang Z
    Medicine (Baltimore); 2020 Sep; 99(36):e22100. PubMed ID: 32899091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.